By Julia Karow
This article was originally published May 6.
Following a reexamination request by Life Technologies, the United States Patent and Trademark Office, in a non-final action, recently rejected all claims in two of four sequencing-related patents owned by Illumina that are at the center of an ongoing lawsuit between Life Tech and Illumina.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
